DePuy Synthes
BSpinoff of Johnson & Johnson (JNJ) · Medical Devices · Expected Mid-2027
~$9.3B orthopedics; J&J says a spin is currently preferred after alternatives were explored, and reported Smith & Nephew combination talks collapsed (FT, October 23, 2026); the 10-Q now guides to mid-2027
Snapshot Across Reports
| Oct 30, 2026 | Sep 30, 2026 | Aug 31, 2026 | Jul 31, 2026 | May 31, 2026 | |
|---|---|---|---|---|---|
| Status | Upcoming | Upcoming | Upcoming | Upcoming | Upcoming |
| Investment Grade | B | B | B | B | No grade |
| Revenue | ~$9.3B | ~$9.3B | $9.3B | $9.3B | $9.3B |
| Expected Date | Mid-2027 | H2 2027 | H2 2027 | H2 2027 (decision overdue) | Late 2026 / 2027 |
⚠ Auto-generated profile — not editorially reviewed.
This summary is compiled automatically from our tracked report data. A reviewed in-depth analysis is planned. For further detail ▸ read the Oct 30, 2026 report.